|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||6.24 - 6.46|
|52 Week Range||3.76 - 7.20|
|Beta (3Y Monthly)||0.56|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 11, 2019 - Apr 15, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.44|
Companies in the cannabis industry are working on producing new products for consumers, some of which containing hemp-derived cannabidiol. Leafbuyer Technologies Inc (OTC:LBUY), India Globalization Capital Inc (OTC PINK: IGCC), KushCo Holdings Inc (KSHB), and Innovative Industrial Properties Inc (IIPR) are 4 pot stocks leading the pack as we close out this week. Given the nascency of the global cannabis industry, consumers now, more than ever, need access to materials and data top help them better understand the products they plan on using.
KushCo Holdings, Curaleaf Holdings and Acreage Holdings are beloved by the momentum crowd, but not by professional investors.
CORAL GABLES, FL / ACCESSWIRE / February 21, 2019 / The 2019 year has already shown a significant amount of upward momentum for the marijuana stock market. A key reason for this tidal shift of positive energy is due to the fact that companies throughout the industry are progressing because many states in the U.S., as well as Canada, have passed legislation in favor of legalizing cannabis. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Emerald Health Therapeutics Inc (EMHTF) (TSX-VEMH), CannTrust Holdings Inc (OTC PINK: CNTTF), and KushCo Holdings Inc (KSHB) are 4 pot stocks that could test this week's highs.
Seaport Global turned bullish on cannabis stocks Thursday, initiating coverage on a dozen names. However, some of the most popular U.S. cannabis stocks are not among the firm’s top picks. The Analyst Seaport ...
Marijuana stocks may not have had a stellar year in 2018. But, this year could easily bring better news as things continue to expand and more new marijuana markets open up.
GARDEN GROVE, Calif., Feb. 19, 2019 -- KushCo Holdings, Inc. (OTCQB: KSHB) (“KushCo” or the “Company”), the parent company of innovative cannabis industry leaders such as Kush.
CORAL GABLES, FL / ACCESSWIRE / February 15, 2019 / The marijuana stock market has seen a huge boost this past year, which could spell out a true first-mover advantage as we continue into the new year. ...
Cannabis stocks are having a blistering start to 2019. The sector appeared to have peaked in the fall of 2018. As many had warned, marijuana stocks turned sharply lower following Canada's legalization going into effect in a classic "sell the news" event. However, since then, the tide has turned. This year, pot stocks are back with the sector ETF posting a 50% move off the lows. * 9 U.S. Stocks That Are Coming to Life Again Not surprisingly, this enthusiasm has carried both recreational and medicinal cannabis stocks higher. For today, let's focus on the medicinal space. The recreational plays have been getting more attention lately with all the blockbuster partnerships. However, there are some interesting business stories developing in the medical cannabis stock space as well.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSource: Shutterstock Aurora Cannabis (ACB)Aurora Cannabis (NYSE:ACB) is getting a ton of attention this week thanks to its recent earnings report. Aurora initially disappointed the market as its revenue numbers came in below expectations. This point raised some confusion. The company reported CAD $48 million in cannabis revenues, which was below expectations. Total revenues, which included a few other minor accounting items, hit CAD $54 million. That number beat analysts' outlooks.ACB stock initially dropped about 5% following earnings. Since then, it reversed course and traded higher. That makes sense; at the end of the day, it's the forward outlook that matters here, not a few million dollars of revenue this past quarter. On that note, the most solid bullish argument for ACB stock is that its patient base is surging. This quarter, it reported more than 73,000 active registered patients -- more than 200% growth from the same quarter last year.Of course, bears will point to the huge losses that Aurora is reporting. The company lost CAD $238 million, which blows the revenue figure of CAD $54 million out of the water. Some of these losses appear tied to ramping up operations. For the back half of the year, Aurora projects positive EBITDA, and much smaller net income losses. That, combined with relatively downbeat sentiment here, make ACB stock a buy within its sector. Do be careful though, Aurora needs to start posting much smaller losses as its customer base increases or investors will lose patience fairly quickly. GW Pharmaceuticals (GWPH)When it comes to medical cannabis stocks -- as opposed to the recreational lane -- GW Pharmaceuticals (NASDAQ:GWPH) is the king. GW Pharmaceuticals got involved with its epilepsy drug well before the flood of marijuana stocks hit the market last year.GW capitalized on its first-mover advantage by already securing FDA approval for its therapy while other cannabis stocks are still getting their operations up and going. The company has gotten widespread insurance coverage approval for its drug, Epidiolex. * The 7 Best Video Game Stocks to Power Up Your Portfolio! Earlier this year GW confirmed that the vast majority of both fee-for-service and managed- Medicaid providers will cover Epidiolex. Big private providers, such as Express Scripts (NASDAQ:ESRX) are on board as well. GW recently raised $300 million. That cash should give it plenty of runway to get Epidolex sales up and going while also funding its numerous other in-progress clinical trials. For a pureplay marijuana biotech stock, it's hard to top GWPH.Source: Shutterstock Cara Therapeutics (CARA)Cara Therapeutics (NASDAQ:CARA) is a bit more undercover as a cannabis stock. The company specializes in various therapeutic treatment alternatives that can serve as alternatives to opioids. As we've seen in recent months, opioids are a crisis in America. An estimated 30,000 people or so die from overdoses every year.This opens an opportunity for Cara, which I previously described. As it is, Cara has various drug therapies in development for pain management. Some of these involve cannabinoids, although its lead clinical candidate does not. In any case, with China increasingly in the news, CARA stock should shine as doctors look for alternatives to dangerous traditional opioids. CARA stock is up from $12 to $17 recently and could rise a lot farther once it picks up more backers from the medical marijuana stock community.Source: Shutterstock KushCo Holdings (KSHB)KushCo Holdings (OTCMKTS:KSHB) is arguably the clearest medical marijuana distribution play in the United States at this time. The company used to be called Kush Bottles, which shows the company's main product line. However, KushCo has branched out past just packaging to provide a variety of supplies for medicinal marijuana sales. By partnering with more than 5,000 pharmacies and dispensaries around the world, KushCo has established a powerful first-mover advantage in its field.That said, there are reasons for caution with KSHB stock. You might think that this is a cheap stock. It is trading for less than $6 and is not listed on a major stock exchange. Despite those factors, KushCo has a market cap of more than $500 million, as the company has issued many shares to fund its growth. * The 3 Best Chinese Stocks to Buy for a Long-Term Portfolio As appealing as the "picks and shovels" play on the marijuana industry sounds, KSHB stock comes with risks. That $500 million market cap is backed by just $50 million or so in current assets, putting a 10x valuation multiple on its property, inventory, cash, and so on. Also, you should take note of the company's gross margin. Its gross margin has plummeted from 35% to 13% in recent quarters, resulting in KushCo making increasingly large losses despite growing revenues. KushCo has an interesting business model and a strong advantage from its robust distribution partnerships. But it needs to start showing that the business can turn profits before the stock can find further upside.Source: Shutterstock Pyxus International (PYX)What happens when a struggling more-than-century old tobacco company turns itself into a marijuana play? The stock soars. Meet the company previously called Alliance One, now known as Pyxus International (NYSE:PYX). For the past two decades or so, Alliance One showed flat to declining revenues as its tobacco business declined. So, last summer, using the hemp workaround to avoid legal issues, Pyxus pivoted to the marijuana market and changed its name, and PYX stock flew.In fact, PYX stock soared from $13 at the start of 2018 to as high as $40, aided by favorable calls from the likes of Citron Research, among others. But the enthusiasm wouldn't last long. Once investors came to their senses, they saw that Pyxus remained heavily in debt and stuck to its legacy tobacco business which faces uncertain prospects going forward. There are a lot of cannabis stocks out there; there aren't many that have more than a billion in debt like Pyxus does.PYX stock soared more than 30% on Tuesday following its earnings report. The market clearly liked what it saw, starting with nearly 10% revenue growth. But the company continues to lose large amounts of money. It reported a GAAP EPS loss of 56 cents per share. It will need a far bigger turnaround to justify anything close to its current share price. The recent share price spike offers speculators an ideal opportunity to sell PYX stock.Source: Shutterstock GB Sciences (GBLX)GB Sciences (OTCMKTS:GBLX) is -- in one way similar -- to KushCo. Despite trading on the Pink Sheets and having a tiny share price, GBLX stock isn't necessarily undervalued. GBLX stock, in fact, sells for under a quarter but, due to a large share count, has a market cap of almost $60 million.I don't want to pick on GBLX stock in particular, as there are a bunch of medical cannabis stocks like GBLX. But it's worth noting one like this to see the pattern. You find a bunch of these, companies that are attached to whatever the current trend is popular but don't have many resources of their own. * Buy Medical Marijuana Stocks for Legal Pot's Next Leg Up In the case of GB Sciences, they had just $3 million in cash as of their last quarterly report. That's not a good sign, as the company has $2.1 million in current liabilities and more than $8 million in total obligations. That will make it hard for the company to achieve its goals in terms of studying Parkinson's and other serious diseases. Yes, GB will put out more press releases and garner more media attention, but without far more cash, the stock isn't going anywhere in the long run. GBLX stock plummeted from a high of 80 cents to just 14 cents last year. If you're already long, take advantage of the recent rebound to get out at 24 cents -- GBLX will likely go a lot lower in coming months.Source: Shutterstock Lexaria Bioscience (LXRP)Lexaria Bioscience (OTCMKTS:LXRP), like GB Science, is a penny stock on the Pink Sheets exchange. However, LXRP has a lot more credibility and gives us a good example of the contrast between an investable speculation and a risky gamble. Lexaria is a higher-quality medical cannabis stock because it has a strong backer: Altria (NYSE:MO).Altria famously lifted Cronos (NASDAQ:CRON) into the big leagues with its massive investment at $12/share. CRON stock went on to hit $25. Altria got a lot less attention with its recent investment in Lexaria, but it may end up having a similar effect. Earlier this year, Altria agreed to invest up to $12 million into Lexaria.Why did it do that? Lexaria has a novel patented technique for oral delivery of drugs. Obviously, this potentially has a huge market in the medicinal marijuana space. As it is, Altria has validated the technology by investing in it and seeking to commercialize it for nicotine. At $1.30 a share and a $100 million market cap, LXRP stock is still highly speculative. But unlike many medical cannabis stocks, Lexaria has promising technology and enough financial backing to potentially deliver strong results for its investors.At the time of this writing, Ian Bezek owned MO stock. You can reach him on Twitter at @irbezek. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 7 Best Video Game Stocks to Power Up Your Portfolio! * 7 Forever Stocks to Buy for Long-Term Gains * 5 Self-Driving Car Stocks to Buy Compare Brokers The post Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks? appeared first on InvestorPlace.
The 2019 Benzinga Cannabis Capital Conference in Miami Beach included investor presentations from KushCo, Medicine Man and other major companies in the space. California-based Kushco, which began as a packaging company, is primarily focused on being as much of a business-to-business company as possible, Christoffersen said.
It is expected that within the next year, the U.S. government will move closer to legalizing medical marijuana. And as that eventual legalization progresses, all related stocks will climb higher in anticipation.Statistics indicate that adult Americans are largely behind the push toward the legalization of medical cannabis. A HealthDay/Harris poll taken last year shows 85% of adults in favor of such a move.The reason for such big numbers is the opioid epidemic that has swept across Main Street America. Government pain medication spending drops a full 11% in states where medical cannabis is legal.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe number of patients is already increasing. By the end of 2019, there will be 2.4 million medical marijuana patients -- an increase of 71% from 2014.I do not think there is any question that medical marijuana will be legalized in the United States in the coming years. So long-term investors' best strategy is to get in place now. Getting in Position in Medical Marijuana StocksThere are several ways to profit from this trend. Of course, there are the large U.S.-based marijuana growers and retailers. And legalization would allow Canadian leaders to make a move into the states. Then there are the ancillary plays, which will get a boost as more money is spent on things like packaging and safety regulations. * Buy These 5 Stocks to Play the Megatrend of the Century Today, I'd like to talk about two companies that touch on all of those of themes.Canopy Growth (NYSE:CGC) is the largest company in the marijuana industry today, and it is already setting itself up to make a move into the U.S. Canopy has plans to spend between $100 million and $150 million in the state of New York to establish a large hemp cultivation and extraction facility. By focusing on hemp, which was recently made legal, the company is able to get around the current federal marijuana laws.This is just the beginning for Canopy. It has big plans for the U.S. And considering the company is already a leader in Canada, it has the ability to scale quickly once the laws are changed.KushCo Holdings (OTCMKTS:KSHB) is a leading supplier of picks and shovels to the marijuana industry. Its distribution platform includes everything from specialized packaging to supplies to vaporizer products to hydrocarbons, accessories, and branding products.The California-based company is diverse, working with more than 5,000 legally operated medical and adult-use dispensaries, growers and producers on several continents. It stands to be a major winner in the U.S. as well as more states legalize marijuana, so a change to the federal law would be a huge boom to sales.Canopy and KushCo are just two of a very long laundry list of stocks that would benefit from the expansion of medical marijuana. If you're interested in learning about more, be sure to check out my Investment Opportunities newsletter today.Matthew McCall is the founder and president of Penn Financial Group, an investment advisory firm, as well as the editor of Investment Opportunities and Early Stage Investor. He has dedicated his career to getting investors into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA), +1,044% in Tesla (TSLA), +611% in Liquefied Natural Gas Limited (LNGLY), +324% in Bitcoin Services (BTSC), just to name a few. If you're interested in making triple-digit gains from the world's biggest investment trends BEFORE anyone else, click here to learn more about Matt McCall and his investments strategy today. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks That Every 20-Year-Old Should Buy * 10 Best Dividend Stocks to Buy for the Next 10 Months * 10 Monster Growth Stocks to Buy for 2019 and Beyond Compare Brokers The post Buy Medical Marijuana Stocks for Legal Potas Next Leg Up appeared first on InvestorPlace.
CORAL GABLES, FL / ACCESSWIRE / February 11, 2019 / The market surrounding marijuana stocks has continued to maintain a significant presence in media conversations when discussing future industries with the potential for exponential growth. Next Green Wave Holdings Inc (NXGWF) (NGW), KushCo Holdings Inc (KSHB), 1933 Industries Inc (TGIFF), and InMed Pharmaceuticals Inc (IMLFF) are 4 pot stocks making headlines this month. Next Green Wave Holdings Inc (NXGWF) (NGW) is a vertically integrated seed-to-consumer premium medicinal and recreational cannabis company operating in California, the world's largest cannabis market.
KushCo Holdings, Inc. (KSHB) (“KushCo” or the “Company”), the parent company of innovative cannabis industry leaders such as Kush Supply Co., Kush Energy, The Hybrid Creative, and Koleto Innovations, today announced several changes to its executive leadership team. Effective March 1, 2019, Jim McCormick will step down from his role as Chief Operating Officer (“COO”) of KushCo to pursue other opportunities.
High Times Regulation A Offer Formally Extended to June 30; Shares Likely to List Much Sooner By John Jannarone The parent of High Times magazine has formally extended its offer to the general public to June 30, but the shares are likely to list in the next few weeks, a person familiar with the matter […]
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations NEW YORK , Feb. 4, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...
Kush Bottles, Inc. (KSHB) closed at $5.44 in the latest trading session, marking a -1.27% move from the prior day.
How Is Cannabis Stock Kushco Holdings Positioned in January?Stock performanceOn January 29, Kushco Holdings closed at $5.5, ~0.55% higher than its prior day close, ~2% higher YTD, and a ~24% discount over its 52-week high of $7.2 on January 11,
HENDERSON, NV / ACCESSWIRE / January 29, 2019 / Cannabis stocks are off to a strong start this week, here are a few to put on your radar. One that many investors may overlook as a cannabis play because ...
These Cannabis Stocks Grew Over 10% Last WeekStock performance On January 25, Innovative Industrial Properties (IIPR) stock price closed at $59.94, ~3.52% higher than its closing price of $57.90 on January 24 and ~10% higher compared than
HENDERSON, NV / ACCESSWIRE / January 28, 2019 / With the market on an upward trajectory, now's the time to look at a few ways to play one of the fastest growing industries within the public markets…cannabis. ...
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com GARDEN GROVE, Calif. , Jan. 28, ...
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , Jan. 25, 2019 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications ...